SHUKLA SANJAY (President and CEO) exercised options at ATYR PHARMA INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/6/2023ACC: 0001209191-23-007362
Officer· President and CEO
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.38K acquired · 10.38K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
+10.38K
Price / share
—
Trade value
—
% of position
20.4%
2/3/2023
50.80K→61.17K
Total
Net shares
+10.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/3/2023 | M · Option Exercise | +10.38K | — | — | 20.4% | 50.80K | 61.17K |
| Total | +10.38K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
10.38K shares
Shares
−10.38K
Strike price
Held after
31.13K
Exercisable
—
2/3/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock10.38K shares | 2/3/2023 | M · Option Exercise | −10.38K | — | 31.13K |